Literature DB >> 27010136

Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma.

L Zhou1, Y-M Qu, X-M Zhao, Z-D Yue.   

Abstract

OBJECTIVE: Many studies informed that microRNAs (miRNAs) could function as diagnostic and prognostic indicators in several cancers. The prognostic value of miR-454 in hepatocellular carcinoma has not been investigated. PATIENTS AND METHODS: A total of 265 patients with HCC were obtained in this retrospective study between June 2009 and July 2014. qPCR was conducted to evaluate the expressed amount of the miR-454. The Kaplan-Meier method was conducted to explore the survival status of HCC patients. The log-rank test was used to analyze differences in survival rates.
RESULTS: The expression of miR-454 was significantly upregulated in HCC tissues compared with adjacent non-cancerous tissues (p < 0.001). High levels of miR-454 in HCC tissues were correlated with a low 5-year overall survival (OS) (p < 0.001). Moreover, patients with high miR-454 expression had decreased disease-free survival (DFS) (p < 0.001). Furthermore, multivariate analysis showed that up-regulation of miR-454 was an independent prognostic factor for both 5-year OS (p = 0.013) and 5-year DFS (p = 0.008).
CONCLUSIONS: We firstly prove that expression of miR-454 may be a novel and valuable prognostic factor in HCC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27010136

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  MiRNA-610 acts as a tumour suppressor to depress the cisplatin resistance in hepatocellular carcinoma through targeted silencing of hepatoma-derived growth factor.

Authors:  Yongqing Xu; Helin Wang; Weike Gao
Journal:  Arch Med Sci       Date:  2019-09-12       Impact factor: 3.318

2.  LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer.

Authors:  Xiaohua Li; Lili Hou; Lei Yin; Shuai Zhao
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.

Authors:  Yue Zhang; Chao Wei; Cong-Cong Guo; Rong-Xiu Bi; Jin Xie; Dong-Hui Guan; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-09-14

4.  High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer.

Authors:  Zhi-Gang Cao; Jun-Jing Li; Ling Yao; Yan-Ni Huang; Yi-Rong Liu; Xin Hu; Chuan-Gui Song; Zhi-Ming Shao
Journal:  Oncotarget       Date:  2016-10-04

5.  Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.

Authors:  Xing Bao; Tingting Ren; Yi Huang; Kunkun Sun; Shidong Wang; Kuisheng Liu; Bingxin Zheng; Wei Guo
Journal:  Cell Death Dis       Date:  2017-02-09       Impact factor: 8.469

6.  MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met.

Authors:  Yan Guo; Min Tao; Min Jiang
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

7.  Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.

Authors:  De-Ying Wang; Na Li; Yu-Lan Cui
Journal:  Cancer Res Treat       Date:  2020-03-03       Impact factor: 4.679

8.  miR-454-3p promotes of human glioma cell growth by targeting EGR3.

Authors:  Guoliang Shen; Jian Wu; Zhaohui Mou; Danlong Chen; Li Liu; Xing Li
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

9.  Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.

Authors:  Feng-Jie Lin; Xian-Dong Lin; Lu-Ying Xu; Shi-Quan Zhu
Journal:  Mol Cells       Date:  2020-10-31       Impact factor: 5.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.